Disease Management Education for Liver Cancer Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new educational program to help individuals manage liver conditions like fibrosis (scarring) or steatosis (fatty liver) to prevent liver cancer. Participants will receive information on lifestyle changes, such as diet and exercise, through a series of text messages. The trial includes two groups: one will begin the Behavioral Intervention program immediately, while the other will start after six months. Individuals with liver issues who are overweight, have diabetes, or exhibit certain metabolic risks may be suitable candidates if they have a smartphone and can receive text messages. As an unphased trial, this study provides a unique opportunity to contribute to innovative educational approaches for liver health management.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants can be on specific drug treatments for conditions like high blood pressure, high triglycerides, or low HDL-cholesterol, so it seems likely that some medications may be continued.
What prior data suggests that this behavioral intervention is safe?
Research shows that the types of behavioral programs used in this trial are usually easy for people to handle. Studies on lifestyle changes indicate that these programs can lead to positive short-term health benefits without major safety issues. Reports have not indicated negative effects from these programs, as they mainly involve changes in diet, exercise, and health education.
Although these programs might not always result in permanent lifestyle changes, they are considered safe for participants. Evidence suggests that participants should not expect harmful side effects from taking part in these programs.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on a behavioral intervention for liver cancer prevention, offering a new angle compared to traditional methods like surgery, chemotherapy, or targeted therapy. This intervention emphasizes disease management education, aiming to empower participants with knowledge and strategies to prevent liver cancer through lifestyle changes. Unlike conventional treatments that address liver cancer after it develops, this approach seeks to reduce the risk proactively, which could lead to fewer cases and better outcomes in the long run. The trial's unique feature of offering both immediate and delayed interventions allows researchers to compare and understand the timing's impact on effectiveness, potentially refining future prevention strategies.
What evidence suggests that this trial's treatments could be effective for liver cancer prevention?
Research has shown that staying physically active can greatly reduce the risk of hepatocellular carcinoma (HCC), a common type of liver cancer. Regular exercise can lower the risk of HCC by about 30%. Programs that help people change their habits have demonstrated positive short-term results in reducing risk factors for liver diseases. This trial will compare two approaches: an immediate behavioral intervention and a delayed intervention. Although the long-term effects remain unclear, these programs are still important for maintaining liver health. Additionally, mobile health (mHealth) tools effectively share crucial information about preventing liver cancer. These findings suggest that changing behaviors can powerfully manage liver health and prevent cancer.678910
Who Is on the Research Team?
Karen Basen-Engquist, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Adults with liver fibrosis or steatosis and risk factors for cirrhosis, such as chronic hepatitis B or C, diabetes, high triglycerides, pre-diabetes, obesity, or metabolic abnormalities. Participants must be over 18 years old and able to communicate in English or Spanish. They need smartphone access but cannot join if pregnant, planning pregnancy soon, have exercise/diet restrictions due to medical conditions or surgery plans.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Immediate Intervention
Participants receive a 6-month self-management intervention to help implement behavioral changes to manage their disease
Delayed Intervention
Participants in the wait-list control group receive the intervention after their 6-month assessment
Follow-up
Participants are monitored for changes in fibrosis and behavioral risk factors after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Intervention
- Control Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Cancer Prevention Research Institute of Texas
Collaborator